Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 4
2001 4
2002 1
2003 1
2004 6
2005 4
2006 5
2007 6
2008 20
2009 14
2010 14
2011 19
2012 21
2013 22
2014 19
2015 21
2016 23
2017 32
2018 31
2019 31
2020 34
2021 31
2022 45
2023 45
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies.
Sands BE, D'Haens G, Panaccione R, Regueiro M, Ghosh S, Hudesman D, Ahmad HA, Mehra D, Wu H, Jain A, Petersen A, Osterman MT, Afzali A, Danese S. Sands BE, et al. Among authors: panaccione r. Clin Gastroenterol Hepatol. 2024 May 7:S1542-3565(24)00405-1. doi: 10.1016/j.cgh.2024.03.042. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38723981
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
Schreiber S, Hunter Gibble T, Panaccione R, Rubin DT, Travis S, Hibi T, Potts Bleakman A, Panni T, Favia AD, Kayhan C, Atkinson C, Saxena S, Dubinsky MC. Schreiber S, et al. Among authors: panaccione r. Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08434-5. Online ahead of print. Dig Dis Sci. 2024. PMID: 38700629
Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy.
Rowan C, Yeaman F, Ernest-Suarez K, Martin ML, Panaccione R, Shukla T, Grossi M, Vlasschaert M, Novak K, Seow C. Rowan C, et al. Among authors: panaccione r. Inflamm Bowel Dis. 2024 May 2;30(5):868-870. doi: 10.1093/ibd/izae076. Inflamm Bowel Dis. 2024. PMID: 38591862 Free PMC article.
Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study.
Bernstein CN, Panaccione R, Nugent Z, Marshall DA, Kaplan GG, Vanner S, Dieleman LA, Graff LA, Otley A, Jones J, Buresi M, Murthy S, Borgaonkar M, Bressler B, Bitton A, Croitoru K, Sidani S, Fernandes A, Moayyedi P. Bernstein CN, et al. Among authors: panaccione r. Inflamm Bowel Dis. 2024 Mar 27:izae055. doi: 10.1093/ibd/izae055. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38537257
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, Rubin DT, Lindsay JO, Siffledeen J, Lukin DJ, Wright J, Watanabe K, Ford S, Remple VP, Lacerda AP, Dubcenco E, Garrison A, Zhou Q, Berg S, Anyanwu SI, Schreiber S. Peyrin-Biroulet L, et al. Among authors: panaccione r. Clin Gastroenterol Hepatol. 2024 Mar 15:S1542-3565(24)00253-2. doi: 10.1016/j.cgh.2024.02.026. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38492904 Free article.
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
Colombel JF, Hisamatsu T, Atreya R, Bresso F, Thin L, Panaccione R, Parra RS, Ford S, Remple VP, Lacerda AP, Anyanwu SI, Mallick M, Garrison A, Regueiro M. Colombel JF, et al. Among authors: panaccione r. Clin Gastroenterol Hepatol. 2024 Mar 15:S1542-3565(24)00254-4. doi: 10.1016/j.cgh.2024.02.027. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38492903 Free article.
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Hunter Gibble T, Abreu MT, Lee S, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Arora V, Panaccione R, Dignass A. Sands BE, et al. Among authors: panaccione r. Inflamm Bowel Dis. 2024 Mar 9:izae024. doi: 10.1093/ibd/izae024. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38459910
416 results